ARTICLE | Clinical News
Metaxalone SoluMatrix tablets: Completed Phase I enrollment
December 10, 2012 8:00 AM UTC
iCeutica completed enrollment of an undisclosed number of healthy volunteers in a U.S. Phase I trial comparing Metaxalone SoluMatrix tablets vs. Skelaxin metaxalone from Pfizer Inc. (NYSE:PFE, New Yo...